Lipids are taken up by the heart when availability is high. High plasma concentrations of free fatty acids lead to increased lipid storage in the heart.
ID
Bron
Verkorte titel
Aandoening
possible mechanism for cardiac lipid accumulation in obesity is studied in healthy lean mean.
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Cardiac lipid content after high or low free fatty acid condition.
Achtergrond van het onderzoek
To test whether the myocardium is storing more lipids when free fatty acid concentration is elevated, subjects cycled for two hours in the fasted state, which is well known to lead to an increase in free fatty acid concentrations. When subjects stay fasted during recovery, free fatty acid concentration stay high. However, when glucose drinks are administered before and during the test day, the elevation of free fatty acids is completely blunted. In the two conditions (high vs low levels of free fatty acids), cardiac lipid content and cardiac function is determined.
Doel van het onderzoek
Lipids are taken up by the heart when availability is high. High plasma concentrations of free fatty acids lead to increased lipid storage in the heart.
Onderzoeksopzet
Cardiac lipid content is measured at the beginning of the test day, after cycling and after 3 hours of recovery. Cardiac function and energy status is only determined after recovery.
Onderzoeksproduct en/of interventie
Subjects cycled for 2 hours at 50% of the predetermined maximal work load in the fasted state and stay fasted during a three hour recovery period. This procedure is known to increase free fatty acid concentration. Before and after exercise and after recovery, cardiac lipid content is determined by Magnetic Resonance Spectroscopy. Cardiac function and energy status is determined at the end of the test day, after recovery. During the test day, blood samples are taken at multiple time points and fat- and carbohydrate oxidation is determined by indirect calorimetry. The same procedure is repeated with glucose supplementation to blunt the increase in free fatty acids. The two treatments (with/without glucose) were randomized.
Publiek
Department of Human Biology
Maastricht University Medical Center
Patrick Schrauwen
Department of Human Biology
Maastricht University Medical Center
Maastricht 6200 MD
The Netherlands
+31(0)43-388 15 02
p.schrauwen@hb.unimaas.nl
Wetenschappelijk
Department of Human Biology
Maastricht University Medical Center
Patrick Schrauwen
Department of Human Biology
Maastricht University Medical Center
Maastricht 6200 MD
The Netherlands
+31(0)43-388 15 02
p.schrauwen@hb.unimaas.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Male sex;
2. Age: 18-35 years;
3. BMI: 18-25;
4. Stable dietary habits (no weight gain or loss of >8% of bodyweight in the last 6 months);
5. No medication.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Known cardiovascular disease, diabetes or dyslipididemia;
2. Contra-indication for MRI (electronic implants, iron containing corpora alinea in eyes, certain hearing aids and certain artificial heart valves);
3. Weight gain/loss > 8% of body weight;
4. Medication use.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL1807 |
NTR-old | NTR1917 |
Ander register | METC Maastricht University Medical Center : MEC 08-3-063 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |